Pharma — India Trademark Cases
454 decisions indexed
Page 9 of 16 · 454 total
Hamdard National Foundation (India) v.Sadar Laboratories Pvt. Limited
The Delhi High Court dismissed the plaintiffs' application for an ad interim injunction against Sadar Laboratories, which was seeking protection for its well-known trademark 'Rooh Afza'. The court found that while 'Rooh Afza' may be a strong mark, the defendant's use of 'Dil Afza' did not necessarily cause consumer confusion, especially given the long history and peaceful co-existence of similar marks in the pharmaceutical market. However, the defendant was directed to maintain detailed sales accounts during the pendency of the suit.
Syncom Formulations (I) Ltd v.Cratus Pharma Limited
Syncom Formulations (I) Ltd filed a Commercial IP Suit against Cratus Pharma Limited alleging infringement of its registered trade marks ("CRATUS" and "CRATUS LIFE CARE"). The parties subsequently reached an amicable settlement, which was accepted by the court.
GLAXO GROUP LIMITED v.CIAN HEALTHCARE LIMITED
The Delhi High Court formally decreed the suit between Glaxo Group Limited and Cian Healthcare Limited based on a settlement agreement reached through mediation. The defendant agreed to pay Rs. 1,50,000 towards the plaintiff's claim and costs, and crucially, consented not to use the trademark 'BETASOL' for their products. This resolution allowed both parties to conclude the litigation amicably.
Allergan, Inc. v.The Registrar Of Trade Marks
Allergan, Inc. challenged the Registrar of Trade Marks' refusal to register its trademark in the Delhi High Court. The court initiated proceedings by issuing notice to the Registrar, allowing the defendant two weeks to file a response. This order sets the stage for a substantive hearing on whether Allergan meets the criteria for trademark registration.
Toasha Agencies And Another v.Siddhant Choudharyand Anr.
The Delhi High Court framed a comprehensive set of issues in the trademark passing-off suit filed by Toasha Agencies against Siddhant Choudhary and others. The core disputes revolve around whether the plaintiffs are lawful proprietors of the 'TOASHA' trade name, if they possess distinctive goodwill, and crucially, whether the defendants have engaged in passing off or unfair competition. The court directed both parties to file their lists of witnesses and evidence, setting the stage for a full trial.
Sun Pharmaeutical Industries Limited v.Indkus Nexa
Sun Pharmaeutical Industries Limited filed a civil suit against Indkus Nexa and Indo Himalaiyan Herbs Inc. alleging trademark infringement, copyright violation, and passing off concerning its registered mark 'VOLINI'. The plaintiff sought permanent injunctions to stop the use of similar marks like 'VOLINEX' and imitation packaging. The dispute was ultimately resolved through a memorandum of compromise signed by both parties.
Galpha Laboratories Limited v.Shivansh Shrivastava
The Plaintiff, a pharmaceutical company, filed an opposition against the Defendant's application for the trade mark BFOLIN. The court examined the similarity between the established mark B-COLEN and the proposed mark BFOLIN. Satisfied that there is a prima facie case of likelihood of confusion, the court granted an ad-interim injunction.
Himalaya Wellness Company & Ors. v.Abony Healthcare Limited Through Its Directors & Anr.
The Delhi High Court granted an ex-parte ad interim injunction in favor of Himalaya Wellness Company against Abony Healthcare Limited. The suit alleged trademark infringement, passing off, trade dress infringement, and copyright violation concerning the 'Liv' product line. The court found prima facie evidence of deceptive similarity based on identical packaging elements, color schemes (orange/green), and similar product names ('Liv.52' vs 'Liv.55 DS'). This interim order prevents the defendants from continuing their alleged infringing activities pending the final hearing.
Macleods Pharmaceuticals Limited v.M/S Skynet Placements & Ors.
The Delhi High Court granted an ad-interim injunction in favor of Macleods Pharmaceuticals Limited against M/S Skynet Placements & Ors. The court found a prima facie case that the defendants were using the plaintiff's registered trademark 'MACLEODS' for deceptive purposes, specifically related to fake job offers. Consequently, the defendants were restrained from promoting or offering services under the mark, and banks were directed to freeze specific accounts linked to the alleged fraudulent activity.
Terrace Pharmaceuticals Pvt. Ltd. v.The Controller General Of Patents, Designs and Trademarks & Anr.
In this matter concerning a petition before the Delhi High Court, the court addressed several procedural applications. While certain motions were disposed of, the bench issued a critical direction requiring the petitioner to implead the actual registered proprietors of the trademark in question. This step is necessary because a favorable ruling could lead to the cancellation of their registered mark, ensuring all stakeholders are heard before proceeding with the core dispute.
Macleods Pharmaceuticals Limited v.Nava Healthcare Pvt. Ltd.
The Delhi High Court ruled in favor of Macleods Pharmaceuticals Limited, granting a permanent injunction against Nava Healthcare Pvt. Ltd. and associated defendants for trademark infringement and passing off. The court found that the Defendants' mark 'Blofin-D3 Max' and packaging were identical to the Plaintiff's registered marks ('Bio-D3', 'Bio-D3 Max') used for similar pharmaceutical preparations. Although Defendant No. 1 changed its mark, the injunction was upheld against all parties involved in the collaboration, and costs were awarded to the Plaintiff.
Alkem Laboratories Limited v.Danish Health Care Pvt Ltd & Anr.
The Delhi High Court decreed the suit filed by Alkem Laboratories Limited against Danish Health Care Pvt Ltd following an amicable settlement reached through court mediation. The dispute centered on the alleged infringement of Alkem’s registered trademark ‘ALDIGESIC’ in medicinal preparations. Under the terms of the settlement, the Defendants acknowledged Alkem's rights and agreed to cease using the infringing mark and similar trade dress, further agreeing to withdraw their own pending trademark application for 'ALGESIC'.
Cadila Healthcare Limited v.Pure & Cure Healthcare Pvt. Ltd.
Cadila Healthcare Limited successfully concluded its trademark infringement suit against Pure & Cure Healthcare Pvt. Ltd. by reaching a comprehensive settlement agreement before the Delhi High Court. The defendants formally acknowledged Cadila's absolute proprietary rights in the 'AMLODAC' trademark and committed to ceasing all use of the mark, including recalling existing stock and destroying promotional materials. This resolution allows the suit to be disposed of with a decree reflecting the agreed-upon terms.
Franco Indian Pharmaceuticals Pvt Ltd v.Healthyraj Wellness Enterprises & Anr
The Plaintiff, a pharmaceutical company, sought an interim injunction against the Defendants for using the competing mark DIABIT. The court found that the Defendants' mark was structurally, visually, and phonetically almost indistinguishable from the Plaintiff's registered mark DIAVIT, leading to a significant likelihood of confusion.
Dr.Reddys Laboratories Limited v.West-Coast Pharmaceutical Works Ltd.
In this trademark infringement suit concerning Omeprazole capsules, the Delhi High Court addressed a request for ex parte ad interim relief. While the plaintiff presented an arguable case regarding the deceptive similarity between 'OMEZ' and 'OMES', the court ultimately refused immediate injunction. The judge emphasized that mere prima facie evidence is insufficient; the balance of convenience, irreparable loss, and public interest must be weighed, leading to a decision to allow the defendant a chance to respond.
Alkem Laboratories Ltd. v.Nava Healthcare Pvt. Ltd. & Ors.
In this trademark infringement suit concerning pharmaceutical products, the Delhi High Court addressed the plaintiff's request for immediate interim injunction. The court declined to grant an ex parte order, emphasizing that the defendants had claimed prior use of the mark since 2018 and that public interest required them to be given a chance to respond. Consequently, notice was issued to the defendants, allowing the litigation process to proceed with due consideration for all parties.
Lupin Limited v.Celon Laboraatories Private Limited
Lupin Limited sought an urgent interim injunction in the Bombay High Court against Celon Laboraatories Private Limited for alleged trademark infringement and passing off. The dispute centered on the use of the mark BIVASSA by the defendant, which was deemed deceptively similar to the plaintiff's registered anti-cancer drug mark BEVAZZA. The court found a sufficient prima facie case and granted an ad-interim injunction.
Sun Pharma Laboratories Limited v.Salud Care (India) Private Limited
Sun Pharma Laboratories Limited filed an interim application alleging that Salud Care (India) Private Limited was manufacturing and marketing a pharmaceutical preparation under the mark PROLOMEK, which was confusingly similar to Sun Pharma's registered trademark PROLOMET. The court found a prima facie case of infringement and passing off.
Sun Pharma Laboratories Limited v.Nova Indus Pharmaceuticals And Anr
Sun Pharma Laboratories Limited filed a commercial IP suit alleging trademark infringement and passing off against Nova Indus Pharmaceuticals. The court examined the extreme phonetic and structural similarity between the marks PANTOCID and PANZOCID, finding that there was a sufficient prima facie case.
Cutis Biotech Thr.Its Sole Prop. v.Serum Institute of India Private
This Bombay High Court appeal addressed a dispute over the trademark 'Covishield' between Cutis Biotech and Serum Institute of India. Although both parties had pending applications for the mark, Cutis Biotech sought an interim injunction based on passing off. The court ultimately dismissed the appeal, finding that the balance of convenience did not favor the appellant, especially given the critical public health role of the 'Covishield' vaccine in ongoing vaccination drives.
The Himalaya Drug Company & Ors v.Ashok Kumar & Ors
The Delhi High Court issued interim protective orders in favor of The Himalaya Drug Company against Ashok Kumar & Ors regarding trademark infringement. The court restrained the defendants from using Himalaya's registered logos, trademarks (including 'Himalaya Pure Herbs'), specific domain names like <himalayawelness.com>, and associated email IDs. Furthermore, the court directed the freezing of certain websites and domain names to prevent further unauthorized capitalization on the plaintiff's goodwill.
Franco-Indian Pharmaceuticals Pvt Ltd v.Nutramarck Lifesciences Pvt Ltd
This interim application sought relief concerning the alleged infringement of a trademark (STIMULIV) by the defendant (Nutramarck Lifesciences Pvt Ltd), which was using the mark IMMULIV. The defendant, through its director, provided assurances that they would cease manufacturing and using the impugned marks.
Franco-Indian Pharmaceuticals Pvt Ltd v.Nutramarck Lifesciences Pvt Ltd
This interim application was filed regarding a trademark dispute between Franco-Indian Pharmaceuticals Pvt Ltd and Nutramarck Lifesciences Pvt Ltd. The defendant, through its director Mr Abhinav, stated that they had stopped manufacturing products with the impugned mark IMMULIV and would remove them from e-commerce websites within two weeks.
M/S Nutrica Pusti Healthcare Pvt. Ltd. v.M/S Morepen Laboratories Ltd.
The Delhi High Court dismissed the appeal filed by Nutrica Pusti Healthcare Pvt. Ltd., upholding the Commercial Court's interim injunction against Morepen Laboratories Ltd. The court found that the marks used by the appellants were deceptively similar to those of the respondents, particularly considering the pharmaceutical context and potential for consumer confusion. This judgment reinforces the strict application of trademark principles in the highly regulated pharma sector.
Franco-Indian Remedies Pvt Ltd v.Unihelix Biotech Pvt Ltd
The Plaintiff filed a suit for trademark infringement and passing off regarding its mark FINATE used in cholesterol control formulations. The Defendant was using the mark FERINATE XT. The Court found a prima facie case due to the confusing similarity between the marks, leading to an interim injunction favoring the Plaintiff.
Fdc Limited v.Shripal Mangalchand Jain
Fdc Limited filed a Commercial IP Suit against Shripal Mangalchand Jain regarding trademark infringement. The dispute centers on FDC's mark PYRIMON (used for anti-bacterial isolation) versus the Defendant's mark PRIMON-N (used for birth control pills and menopausal hormone therapy).
Ajanta Pharma Limited v.Uniray Life Sciences
Ajanta Pharma Limited filed an interim application alleging that Uniray Life Sciences was using the competing mark ACNO GEL, which infringed upon Ajanta's registered trademarks (ACNO and ACNO-C) used for acne treatment. The court found a sufficient prima facie case and granted an ad-interim injunction.
Laboratories Griffon Pvt Ltd v.Ramesht Industry Pvt Ltd
The Plaintiffs, Laboratories Griffon Pvt Ltd, filed a suit alleging trade mark infringement and passing off against the Defendants, Ramesht Industry Pvt Ltd. The dispute centers on the use of identical or confusingly similar marks (GLIMET, GLIMET-1, GLIMET-2) for pharmaceutical products used in treating diabetes. The Court found a prima facie case and granted an ad-interim injunction.
Dr.Reddys Laboratories Limited v.Eros International Media Limited And Anr.
Dr. Reddy's Laboratories sought an urgent interim injunction to prevent the release of a feature film, 'Haathi Mere Saathi,' alleging that its brand mark 'DRL' was being used in a derogatory manner within the movie plot. The Delhi High Court ultimately dismissed the plaintiff's application, finding that Dr. Reddy's failed to meet the three-pronged test for granting an injunction. The court held that the balance of convenience favored the defendants due to their substantial investment in the film production.
Centaur Pharmaceuticals Pvt Ltd v.BRD Medilabs & Anr
Centaur Pharmaceuticals Pvt Ltd filed a Commercial IP Suit against BRD Medilabs & Anr regarding trademark infringement. The court decreed the suit in specific terms, requiring the defendants to apply for the cancellation of their registered mark 'Sanaret Labs' and withdraw their service mark application within four weeks.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.